Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis

Enhanced and aberrant T cell trafficking following total body irradiation: a gateway to graft-versus-host disease?

(2013) Fabrizio Vianello et al.   BRITISH JOURNAL OF HAEMATOLOGY

Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence

(2013) K. van Besien   Hematology-American Society of Hematology Education Program

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes

(2012) C. G. Brunstein et al.   BLOOD

Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients

(2012) D A Portier et al.   BONE MARROW TRANSPLANTATION

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

(2012) Claudio Anasetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment

(2012) Anthony D. Sung et al.   Stem Cells Translational Medicine

Quality of Life of Patients after Allogeneic Hematopoietic Stem Cell Transplantation with Antihuman Thymocyte Globulin

(2011) Zheng-Ping Yu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

(2011) M. E. D. Flowers et al.   BLOOD

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

(2011) R. J. Soiffer et al.   BLOOD

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius

(2011) G. Socie et al.   BLOOD

High Rabbit-Antihuman Thymocyte Globulin Levels Are Associated with Low Likelihood of Graft-vs-Host Disease and High Likelihood of Posttransplant Lymphoproliferative Disorder

(2010) Peter J. Podgorny et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Feasibility of BU, CY and etoposide (BUCYE) and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience

(2010) D H Yoon et al.   BONE MARROW TRANSPLANTATION

The Addition of 400 cGY Total Body Irradiation to a Regimen Incorporating Once-Daily Intravenous Busulfan, Fludarabine, and Antithymocyte Globulin Reduces Relapse Without Affecting Nonrelapse Mortality in Acute Myelogenous Leukemia

(2009) James A. Russell et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

(2009) Jürgen Finke et al.   LANCET ONCOLOGY

Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide

(2008) Christopher N. Bredeson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose

(2008) M Remberger et al.   BONE MARROW TRANSPLANTATION

Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen–Identical Sibling Transplants for Adults With Leukemia

(2008) Theresa Hahn et al.   JOURNAL OF CLINICAL ONCOLOGY

Recognizing and Managing Chronic Graft-Versus-Host Disease

(2008) S. J. Lee et al.   Hematology-American Society of Hematology Education Program